Oral Health and People With Systemic Sclerosis
NCT01817361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210
Last updated 2017-03-29
Summary
The public health impact of this study will be the application of the greater understanding of the oral health status, oral health related behaviors, and quality of life of patients with systemic sclerosis (scleroderma or SSc). It is hoped that risks and protective factors can be identified to be associated with the oral health status of adults with systemic sclerosis,leading to the development of interventions for improved oral health in this population,and providing the basis for a larger study of oral health problems of adults with systemic sclerosis.
Conditions
Sponsors & Collaborators
-
University of Alabama at Birmingham
lead OTHER
Principal Investigators
-
Hon K Yuen, PhD · University of Alabama at Birmingham
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients
NCT04132206 ·Status: RECRUITING
-
Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma
NCT07326033 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Oral Type I Collagen for Relieving Scleroderma
NCT00005675 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320 ·Status: COMPLETED
-
Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis
NCT03508375 ·Status: UNKNOWN ·Phase: NA
-
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
NCT05300932 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Evaluation of Muscle Involvement in Systemic Sclerosis
NCT06051773 ·Status: RECRUITING
-
Exercise With Scleroderma Functional Outcomes
NCT06425653 ·Status: COMPLETED ·Phase: NA
-
Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis
NCT02302352 ·Status: UNKNOWN ·Phase: PHASE3
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
NCT02422407 ·Status: COMPLETED
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
NCT00853788 ·Status: COMPLETED
-
What is the Optimal Follow-up for Patients With Systemic Sclerosis?
NCT05103553 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identification of Oral Lesions Through an Autofluorescence System
NCT05942794 ·Status: RECRUITING ·Phase: NA
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention
NCT04588714 ·Status: COMPLETED ·Phase: NA
-
Sacroiliitis in Systemic Sclerosis
NCT01673633 ·Status: COMPLETED
-
Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis
NCT06598982 ·Status: RECRUITING
-
Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis
NCT07209644 ·Status: NOT_YET_RECRUITING
-
Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension
NCT02331225 ·Status: COMPLETED
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
NCT01813279 ·Status: COMPLETED ·Phase: NA
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Primary Sjögren's Syndrome
NCT03765593 ·Status: UNKNOWN